State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 319 actively recruiting studies with Michigan sites out of 319 registered in total. The busiest research areas in Michigan are Prostate Cancer, Advanced Solid Tumor, Solid Tumors. Leading sponsors running trials in the state include University of Michigan, University of Michigan Rogel Cancer Center, National Cancer Institute (NCI). By stage, Michigan trials break down as Phase 1 (57), Phase 2 (97), Phase 3 (88), Phase 4 (10).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 319 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 319. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Advanced Solid Tumor, Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT05826535 Phase 1, Phase 2
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Condition
Relapsed Non-Hodgkin Lymphoma
Enrollment
270 pts
Location
United States, Australia
Sponsor
Lyell Immunopharma, Inc.
NCT06379789 Phase 1, Phase 2
Recruiting
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX G...
Condition
Hemophilia B
Enrollment
130 pts
Location
United States, Australia, Brazil
Sponsor
Regeneron Pharmaceuticals
NCT06844227 N/A
Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Vir...
Condition
Atrial Fibrillation (AF)
Enrollment
1,780 pts
Location
United States, Canada, Greece
Sponsor
McMaster University
NCT07750873 Phase 2
Recruiting
A Trial of CRD-4730 in HFrEF
Condition
Heart Failure With Reduced Ejection Fraction (HFrEF)
Enrollment
525 pts
Location
United States
Sponsor
Cardurion Pharmaceuticals, Inc
NCT06636383 N/A
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Condition
Glycogen Storage Disease Type Ia
Enrollment
140 pts
Location
United States, Brazil, Canada
Sponsor
Ultragenyx Pharmaceutical Inc
NCT05625659 N/A
Recruiting
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breas...
Condition
Breast Cancer
Enrollment
2,032 pts
Location
United States, Canada
Sponsor
American College of Radiology
NCT07817251 Phase 3
Recruiting
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semagl...
Condition
Diabetes Mellitus, Type 2
Enrollment
210 pts
Location
United States
Sponsor
Novo Nordisk A/S
NCT07766161 N/A
Recruiting
Informing Implementation of a Circadian-Focused Intervention for Postpartum Depr...
Condition
Postpartum Depression (PPD)
Enrollment
30 pts
Location
United States
Sponsor
University of Michigan
NCT06107361 N/A
Recruiting
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomi...
Condition
Peripheral Intravenous Vein Catheter Phlebitis
Enrollment
360 pts
Location
United States
Sponsor
Corewell Health East
NCT07186842 Phase 1, Phase 2
Recruiting
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentia...
Condition
Advanced Solid Cancers
Enrollment
245 pts
Location
United States, Australia, Germany
Sponsor
BioNTech SE
NCT07541079 Phase 3
Recruiting
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Gir...
Condition
Early Breast Cancer
Enrollment
300 pts
Location
United States
Sponsor
Genentech, Inc.
NCT07892027 Phase 2
Recruiting
Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory...
Condition
Recurrent Diffuse Large B-Cell Lymphoma
Enrollment
26 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT07265674 Phase 3
Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (P...
Condition
Advanced Biliary Tract Cancer
Enrollment
480 pts
Location
United States
Sponsor
J-Pharma Co., Ltd.
NCT06767514 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
NCT07116967 Phase 3
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants Wit...
Condition
Plaque Psoriasis
Enrollment
3,040 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06538636 N/A
Recruiting
Prediction Augmented Screening Initiative
Condition
Lung Cancer
Enrollment
23,520 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06740630 Phase 3
Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vacci...
Condition
Chickenpox
Enrollment
1,840 pts
Location
United States, Belgium, Colombia
Sponsor
GlaxoSmithKline
NCT07365007 N/A
Recruiting
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemothe...
Condition
Chemotherapy-Induced Peripheral Neuropathy
Enrollment
50 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT07196644 Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants ...
Condition
Solid Tumors Harboring MET Amplification
Enrollment
100 pts
Location
United States, Israel, Japan
Sponsor
AbbVie
NCT05677971 Phase 3
Recruiting
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People ...
Condition
Alpha1-Antitrypsin Deficiency
Enrollment
160 pts
Location
United States, Australia, Austria
Sponsor
Takeda
NCT02735707 Phase 3
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acqu...
Condition
Respiratory Tract Diseases
Enrollment
20,000 pts
Location
United States, Australia, Belgium
Sponsor
UMC Utrecht
NCT07276711 N/A
Recruiting
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
Condition
Aortic Valve Stenosis
Enrollment
663 pts
Location
United States
Sponsor
EmStop Inc
NCT06247787 Phase 1
Recruiting
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine a...
Condition
Recurrent Childhood Acute Myeloid Leukemia
Enrollment
36 pts
Location
United States
Sponsor
Children's Oncology Group
NCT06736574 Phase 3
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With S...
Condition
Heart Failure
Enrollment
1,800 pts
Location
United States, Canada, China
Sponsor
Cytokinetics
NCT06795490 N/A
Recruiting
Families in Balance: Enhancing Household Routines and Reducing Early Childhood O...
Condition
Health Behavior
Enrollment
300 pts
Location
United States
Sponsor
University of Michigan
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology